Neoadjuvant chemotherapy for advanced ovarian cancer

Gynecologic Oncology

Volumn 53, Issue 1, 1994, Pages 33-37

  Schwartz, Peter E ^a   Zheng, Wenxin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028231205     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1994.1083     Document Type: Article

References (18)

1. Cannistra SA. Cancer of the ovary. N Engl J Med 1993;329:1550-9.
2. Schwartz PE. Surgical management of ovarian cancer. Arch Surg 1981;116:99-106.
3. Hoskins WJ. Surgical staging and cytoreductive surgery of epithelial ovarian cancer. Cancer 1993;71:1534-40.
4. McGuire WP, Hoskins WJ, Brady MF, et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6.
5. Hoskins WJ, Bundy BN, Thigpen JT, Omura GA. The influence of cytoreductive surgery on recurrence-free interval and survival in small volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 1992;47:159-66.
6. Harries M, Gore M. Part I: chemotherapy for epithelial ovarian cancer—treatment at first diagnosis. Lancet Oncol 2002;3:529-36.
7. Neijt JP, ten Bokkel Huinik WW, van der Burg MEL, et al. Randomized trail comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian cancer. J Clin Oncol 1987;5: 1157-68.
8. van der Burg MEL, van Lent M, Buyse M, et al. The effects of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med 1995;332: 629-34.
9. Chambers JT, Chambers SK, Voynick IM, Schwartz PE. Neoadjuvant chemotherapy in Stage X ovarian carcinoma. Gynecol Oncol 1990; 37:327-331.
10. Schwartz PE, Chambers JT, Makuch R. Neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol 1994;53:33-7.
11. Schwartz PE, Rutherford TJ, Chambers JT, Kohorn EI, Thiel RP. Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival. Gynecol Oncol 1999;72:93-9.
12. Surwit E, Childers J, Atlas M, et al. Neoadjuvant chemotherapy for advanced ovarian cancer. Int J Gynecol Cancer 1996;6:356-61.
13. Vergote IB, De Wever I, Decloedt J, et al. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer. Semin Oncol 2000;27(Suppl 7):31-6.
14. Kayikciog Lu F, Kose MF, Boran N, Caliskan E, Tulunay G. Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian cancer. Int J Gynecol Cancer 2001;11:466-70.
15. Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopel-vic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993;11:166-72.
16. Sneige N, Fanning CV. Peritoneal washing cytology in women: diagnostic pitfalls and clues for correct diagnosis. Diagn Cytopathol 1992;8:632-40 Discussion 640-2.
17. Taylor KJW, Schwartz PE. Cancer screening in a high risk population: a clinical trial. Ultrasound Med Biol 2001;27:461-6.
18. Kobayashi TK, Teraoka S, Tsujioka T, Yoshida Y. Ciliated ovarian adenocarcinoma cells in ascitic fluid cytology: report of a case with immunocytochemical features. Diagn Cytopathol 1988;4:234-8.